Effectiveness of the Use of the PICSI Dish (Hyaluronan Microdot) in the Selection of Sperm for Intracytoplasmic Sperm Injection (ICSI)

Sponsor
Biocoat (Industry)
Overall Status
Completed
CT.gov ID
NCT00741494
Collaborator
(none)
801
9
5
89

Study Details

Study Description

Brief Summary

The purpose of this study is to determine if using microdots of hyaluronan (PICSI) to select sperm for ICSI will result in increased pregnancies especially with men that have a low hyaluronan binding score (HBA).

Condition or Disease Intervention/Treatment Phase
  • Device: PICSI dish
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
801 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Care Provider)
Primary Purpose:
Treatment
Official Title:
Effectiveness of the Use of the PICSI Dish (Hyaluronan Microdot) in the Selection of Sperm for Intracytoplasmic Sperm Injection (ICSI) for Patients Having a Low Versus High Proportion of Hyaluronan Binding Sperm (HBA)
Study Start Date :
Aug 1, 2008
Actual Primary Completion Date :
Dec 1, 2010

Arms and Interventions

Arm Intervention/Treatment
No Intervention: 1

HBA score over 65% control

No Intervention: 2

HBA score over 65%, non-participant (to even out the participation between patients with low HBA scores and those with high HBA scores)

Active Comparator: 3

HBA score over 65%. PICSI dish is used to select the sperm for ICSI.

Device: PICSI dish
Sperm are added to the PICSI dish. Only those that bind to the hyaluronan microdots are selected for ICSI

Experimental: 4

HBA score less than 65%. PICSI dish used to select sperm for ICSI.

Device: PICSI dish
Sperm are added to the PICSI dish. Only those that bind to the hyaluronan microdots are selected for ICSI

No Intervention: 5

HBA Score less than 65%. Control

Outcome Measures

Primary Outcome Measures

  1. Clinical pregnancy rate [8 weeks post ICSI]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • IVF patients who require the ICSI procedure and whose care is being managed by the clinical and scientific staff of the participating groups, will be included in the study.
Exclusion Criteria:
  • IVF patients who do not require the ICSI procedure will be excluded from the study. In addition the following groups of patients will also be excluded:

  • Patients using testicular sperm.

  • Patients using donor sperm.

  • Patients where the female partner is over 40 years of age

  • Patients who have an initial HBA score less than or equal to 2%

  • Patients who have a sperm count less than or equal to 10,000 motile sperm per ml.

  • Patients who produce less than 4 Metaphase II oocytes

Contacts and Locations

Locations

Site City State Country Postal Code
1 Huntington Reproductive Center Laguna Hills California United States 92653
2 Reproductive Science Center of the Bay Area San Ramon California United States 94583
3 Georgia Reproductive Specialists Atlanta Georgia United States 30342
4 Reproductive Biology Associates Atlanta Georgia United States 30342
5 Fertility Centers of Illinois Chicago Illinois United States 60610
6 CNY Fertility Center Syracuse New York United States 13205
7 Abington IVF and Genetics Toll Center for Reprodcution Abington Pennsylvania United States 19001
8 Center for Reproduction and Infertility, Women and Infants Hospital of Rhode Island Providence Rhode Island United States 02903
9 Seattle Reproductive Medicine Seattle Washington United States 98109

Sponsors and Collaborators

  • Biocoat

Investigators

  • Study Director: Kathryn Worrilow, Ph.D., Biocoat

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00741494
Other Study ID Numbers:
  • 2008PICSI03
First Posted:
Aug 26, 2008
Last Update Posted:
Dec 28, 2010
Last Verified:
Dec 1, 2010

Study Results

No Results Posted as of Dec 28, 2010